Cambridge Investment Research Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Buy
88,393
+4,130
+5% +$69.2K ﹤0.01% 1663
2025
Q1
$1.3M Buy
84,263
+41,600
+98% +$639K ﹤0.01% 1657
2024
Q4
$940K Sell
42,663
-10,873
-20% -$240K ﹤0.01% 1924
2024
Q3
$965K Buy
53,536
+280
+0.5% +$5.05K ﹤0.01% 1878
2024
Q2
$865K Buy
53,256
+6,601
+14% +$107K ﹤0.01% 1877
2024
Q1
$658K Buy
46,655
+7,242
+18% +$102K ﹤0.01% 2030
2023
Q4
$411K Sell
39,413
-3,502
-8% -$36.5K ﹤0.01% 2350
2023
Q3
$438K Buy
42,915
+936
+2% +$9.55K ﹤0.01% 2197
2023
Q2
$316K Sell
41,979
-10,084
-19% -$75.9K ﹤0.01% 2483
2023
Q1
$461K Sell
52,063
-1,404
-3% -$12.4K ﹤0.01% 2153
2022
Q4
$488K Buy
53,467
+4,959
+10% +$45.3K ﹤0.01% 2032
2022
Q3
$391K Buy
48,508
+510
+1% +$4.11K ﹤0.01% 2141
2022
Q2
$361K Buy
47,998
+990
+2% +$7.45K ﹤0.01% 2214
2022
Q1
$441K Sell
47,008
-6,223
-12% -$58.4K ﹤0.01% 2213
2021
Q4
$426K Sell
53,231
-4,011
-7% -$32.1K ﹤0.01% 2245
2021
Q3
$558K Buy
57,242
+14,733
+35% +$144K ﹤0.01% 1960
2021
Q2
$421K Sell
42,509
-6,914
-14% -$68.5K ﹤0.01% 2197
2021
Q1
$570K Buy
49,423
+2,553
+5% +$29.4K ﹤0.01% 1812
2020
Q4
$452K Sell
46,870
-7,320
-14% -$70.6K ﹤0.01% 1837
2020
Q3
$488K Sell
54,190
-118,702
-69% -$1.07M ﹤0.01% 1616
2020
Q2
$2.13M Sell
172,892
-131,930
-43% -$1.63M 0.02% 743
2020
Q1
$2.74M Buy
304,822
+145,683
+92% +$1.31M 0.03% 543
2019
Q4
$1.56M Buy
159,139
+127,245
+399% +$1.25M 0.01% 912
2019
Q3
$219K Buy
31,894
+482
+2% +$3.31K ﹤0.01% 2056
2019
Q2
$290K Sell
31,412
-1,065
-3% -$9.83K ﹤0.01% 1764
2019
Q1
$509K Buy
32,477
+4,911
+18% +$77K ﹤0.01% 1468
2018
Q4
$425K Sell
27,566
-2,151
-7% -$33.2K ﹤0.01% 1417
2018
Q3
$640K Sell
29,717
-5,441
-15% -$117K 0.01% 1300
2018
Q2
$855K Sell
35,158
-3,013
-8% -$73.3K 0.01% 1071
2018
Q1
$652K Sell
38,171
-7,812
-17% -$133K 0.01% 1189
2017
Q4
$871K Buy
45,983
+6,642
+17% +$126K 0.01% 972
2017
Q3
$692K Buy
39,341
+3,135
+9% +$55.1K 0.01% 1032
2017
Q2
$1.2M Buy
36,206
+5,381
+17% +$179K 0.02% 717
2017
Q1
$989K Buy
30,825
+4,564
+17% +$146K 0.02% 731
2016
Q4
$952K Buy
26,261
+173
+0.7% +$6.27K 0.02% 698
2016
Q3
$1.2M Buy
26,088
+1,861
+8% +$85.6K 0.02% 603
2016
Q2
$1.22M Sell
24,227
-1,075
-4% -$54K 0.03% 528
2016
Q1
$1.35M Sell
25,302
-563
-2% -$30.1K 0.03% 457
2015
Q4
$1.7M Buy
25,865
+1,411
+6% +$92.6K 0.04% 392
2015
Q3
$1.38M Buy
24,454
+966
+4% +$54.6K 0.04% 393
2015
Q2
$1.39M Buy
23,488
+1,769
+8% +$105K 0.04% 408
2015
Q1
$1.35M Sell
21,719
-48
-0.2% -$2.99K 0.04% 412
2014
Q4
$1.25M Sell
21,767
-883
-4% -$50.8K 0.04% 418
2014
Q3
$1.22M Buy
22,650
+1,763
+8% +$94.7K 0.04% 449
2014
Q2
$1.1M Buy
20,887
+5,313
+34% +$279K 0.04% 430
2014
Q1
$823K Buy
15,574
+472
+3% +$24.9K 0.03% 490
2013
Q4
$605K Buy
15,102
+358
+2% +$14.3K 0.02% 581
2013
Q3
$557K Sell
14,744
-1,853
-11% -$70K 0.02% 579
2013
Q2
$651K Buy
+16,597
New +$651K 0.03% 442